Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

HPV L1 virus-like particles vaccine NBP615

A human papillomavirus (HPV) vaccine composed of purified virus-like particles (VLPs) comprised of major capsid (L1) proteins from HPV subtypes 6, 11, 16 and 18, that can potentially be used for active immunization against HPV types 6, 11, 16 and 18. Upon intramuscular (IM) administration, the HPV L1 VLPs vaccine NBP615 activates the immune system to produce antibodies against the HPV subtypes. This protects against HPV infection and HPV-related cancers.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:HPV L1 VLPs vaccine NBP615
HPV vaccine NBP615
Code name:NBP 615
NBP-615
NBP615
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search